Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: The SN FNAC study

Journal of Clinical Oncology

Volumn 33, Issue 3, 2015, Pages 258-263

  Boileau, Jean Francois ^a   Poirier, Brigitte ^e   Basik, Mark ^a   Holloway, Claire M B ^f   Gaboury, Louis ^b   Sideris, Lucas ^c   Meterissian, Sarkis ^d   Arnaout, Angel ^h   Brackstone, Muriel ⁱ   McCready, David R ^g   Karp, Stephen E ^j   Trop, Isabelle ^b   Lisbona, Andre ^a   Wright, Frances C ^f   Younan, Rami J ^b   Provencher, Louise ^e   Patocskai, Erica ^b   Omeroglu, Atilla ^d   Robidoux, Andre ^b  

^a MCGILL UNIVERSITY   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h UNIVERSITY OF OTTAWA   (Canada)

ⁱ UNIVERSITY OF WESTERN ONTARIO   (Canada)

^j TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CLINICAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; TUMOR BIOPSY; ULTRASOUND; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AXILLA; BREAST NEOPLASMS; CLINICAL TRIAL; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE DISSECTION; LYMPHATIC METASTASIS; MIDDLE AGED; PATHOLOGY; PROCEDURES;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 84921800084     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.7827     Document Type: Article

References (19)

1. Mansel RE, Fallowfield L, Kissin M, et al: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. J Natl Cancer Inst 98:599-609, 2006
2. Krag DN, Anderson SJ, Julian TB, et al: Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927-933, 2010
3. Xing Y, Foy M, Cox DD, et al: Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93:539-546, 2006
4. Mamounas EP, Brown A, Anderson S, et al: Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: Results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23:2694-2702, 2005
5. Shen J, Gilcrease MZ, Babiera GV, et al: Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109:1255-1263, 2007
6. Newman EA, Sabel MS, Nees AV, et al: Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 14:2946-2952, 2007
7. Gimbergues P, Abrial C, Durando X, et al: Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol 15:1316-1321, 2008
8. Classe JM, Bordes V, Campion L, et al: Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: Results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol 27:726-732, 2009
9. Lyman GH, Temin S, Edge SB, et al: Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 32:1365-1383, 2014
10. Hennessy BT, Hortobagyi GN, Rouzier R, et al: Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23:9304-9311, 2005
11. Giuliano AE, Hunt KK, Ballman KV, et al: Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA 305:569-575, 2011
12. Krag DN, Anderson SJ, Julian TB, et al: Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: Results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881-888, 2007
13. Boughey JC, Suman VJ, Mittendorf EA, et al: Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 (Alliance) clinical trial. JAMA 310:1455-1461, 2013
14. Kuehn T, Bauerfeind I, Fehm T, et al: Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): A prospective, multicentre cohort study. Lancet Oncol 14:609-618, 2013
15. Martin RC 2nd, Chagpar A, Scoggins CR, et al: Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 241:1005-1012, 2005
16. Boughey JC, Suman VJ, Mittendorf EA, et al: The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy: Results from the ACOSOG Z1071 Trial. Presented at the San Antonio Breast Cancer Symposium, San Antonio, TX, December 10-14, 2012
17. McCready DR, Yong WS, Ng AKT, et al: Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and falsenegative rates. JNCI 96:873-875, 2004
18. Rutgers EJ, Donker M, Evelien Straver M, et al: Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial. J Clin Oncol 31, 2013 (suppl 15s; abstr LBA 1001)
19. White J, Mamounas E: Locoregional radiotherapy in patients with breast cancer responding to neoadjuvant chemotherapy: A paradigm for treatment individualization. J Clin Oncol 32:494-495, 2014